Insider Transactions in Q1 2024 at T2 Biosystems, Inc. (TTOO)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2024
|
Michael Terrence Gibbs General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
29
+17.68%
|
-
|
|
Feb 24
2024
|
John M Sprague Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29
+17.06%
|
-
|
|
Feb 24
2024
|
John J Sperzel Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
67
+14.35%
|
-
|
|
Feb 20
2024
|
Brett A. Giffin Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13
+14.44%
|
-
|
|
Feb 20
2024
|
John J Sperzel Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
160
+32.45%
|
-
|
|
Feb 20
2024
|
John M Sprague Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40
+26.32%
|
-
|
|
Feb 20
2024
|
Michael Terrence Gibbs General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
40
+27.4%
|
-
|
|
Feb 14
2024
|
Cr Group L.P. |
BUY
Conversion of derivative security
|
Indirect |
824,220
+50.0%
|
-
|